glp 1 and glaucoma Use of GLP-1 Drugs for Obesity Linked to Lower Risk of Comparative Effects of Glucagon-like Peptide

Besides, cell penetrating peptides seem promising to increase skin permeation of GHK and its derivatives

However, doctors may recommend it in specific cases, such as: Certain metabolic conditions Children taking specific medications Low energy due to medical reasons Neurological conditions where energy metabolism is affected Some studies explore L-carnitine in children with autism or ADHD , but its important to understand that it is not a cure or medication

US Food and Drug Administration (2025) FDA accepts proposal for reasonably likely surrogate endpoint for MASH all-cause mortality or liver-related events

Side effects are generally mild and may include temporary injection-site irritation or occasional headaches

These can include dry skin, higher risk of skin infections, and (ironically) hyperpigmentation, i.e., increased skin darkening